Skip to main content
logo
Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
15.07
+0.97 (6.88%)
At close: Nov 6, 2026, 4:00 PM EST
15.37
+0.30 (1.99%)
After-hours: Nov 6, 2026, 6:16 PM EST

Jade Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
107.2588.4469.39
Short-Term Investments
353.96247.72-
Cash & Short-Term Investments
461.21336.1669.39
Cash Growth
-384.47%-
Prepaid Expenses
10.0512.660.27
Total Current Assets
471.25348.8269.65
Property, Plant & Equipment
0.790.9-
Other Long-Term Assets
0.070.073.15
Total Assets
472.11349.7872.8

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
5.822.021.29
Accrued Expenses
15.2214.399.63
Current Portion of Leases
0.760.13-
Other Current Liabilities
9.77-1.08
Total Current Liabilities
31.5716.5412
Long-Term Debt
--107.6
Long-Term Leases
0.630.72-
Total Liabilities
32.217.26119.6

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Common Stock
0.010.010
Additional Paid-In Capital
711.09506.770.18
Retained Earnings
-270.52-174.39-46.98
Comprehensive Income & Other
-0.660.13-
Total Common Equity
439.91332.52-46.8
Shareholders' Equity
439.92332.52-46.8
Total Liabilities & Equity
472.11349.7872.8

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
1.390.85107.6
Net Cash (Debt)
459.82335.31-38.21
Net Cash Growth
---
Net Cash Per Share
8.6610.69-12.11
Filing Date Shares Outstanding
63.649.325.82
Total Common Shares Outstanding
63.5649.325.82
Working Capital
439.68332.2857.66
Book Value Per Share
6.926.74-8.04
Tangible Book Value
439.91332.52-46.8
Tangible Book Value Per Share
6.926.74-8.04
SEC Filings: 10-K · 10-Q